Commercialised

Product Strength ANDA
(Approved/Filed)		 EU Dossier
(Approved/Filed)		 ANDS
(Approved/Filed)		 Countries for which Dossier are available
Baclofen Tablets 5mg Approved Not Filed Except USA
Baclofen Tablets 10mg Approved Not Filed Except USA
Baclofen Tablets 20mg Approved Not Filed Except USA
Cinacalcet tablets 30 mg Approved Approved Can be offered globally
Cinacalcet tablets 60 mg Approved Approved Can be offered globally
Cinacalcet tablets 90 mg Approved Approved Can be offered globally
Doxazosin tablets 1 mg Filed Not filed Approved in CA Except USA, Canada
Doxazosin tablets 2 mg Filed Not filed Approved in CA Except USA, Canada
Doxazosin tablets 4 mg Filed Not filed Approved in CA Except USA, Canada
Entecavir tablets film coated Tablets 0.5mg Approved Approved Approved in CA Except CA, SEA, Middle east
Entecavir tablets film coated Tablets 1 mg Approved Not filed Except CA, SEA, Middle east
Eplerenone Tablets 25 mg Filed Not Filed Except USA
Eplerenone Tablets 50 mg Filed Not Filed Except USA
Esclicarbazepine Tablets 800 mg Not filed Approved Except USA
Itraconazole Capsules 100 Mg Approved Not Filed Except US, Aus, Canada
Mebeverine HCl Tablets 135 mg Not filed Approved Approved in Aus Except UK, Aus,Europe
Mebeverine SR Capsules 200 mg Not filed Approved Can be offered to USA and ROW
Meclizine Tablets 12.5 mg, 25 mg Not filed Not filed Globally except Aus & New Zealand
Metaxalone tablet 800 mg Approved Not Filed Can be offered globally
Methocarbamol  Tablets 500 mg Approved Not Filed Except  USA
Methocarbamol Film Coated Tablets 750 mg Approved Approved Except USA, Germany
Posaconazole DR Tablets 100 mg Filed Not filed Except USA, Middle East
Propiomazin Tablets 25 mg Not filed Approved Except Scandivian countries
Tamsulosine HCl Capsules 0.4 mg Approved Not Filed Approved in CA Can be offered globally
Tetracycline HCL Capsules 250 mg Approved Not Filed Except USA
Tetracycline HCL Capsules 500 mg Approved Not Filed Except USA
Tolcapone tablets 100 Mg Approved Approved Except USA and Europe

Pipeline

Product Strength Status
FERRIC CITRATE Tablets EQ210 IRON Proof of concept established
Aspirin+Dipyridamole ER Capsules 25/200mg Proof of concept established
Mexiletine Capsules 150mg/200mg/250mg Proof of concept established
Diflunisal tablets 500 mg Proof of concept established
Dipyridamole ER capsules 200 mg Proof of concept established
Solifenacin & Tamsulosin PR tablets 6 mg/0.4 mg Proof of concept established
Hydralazine HCl tablets 10 mg, 25 mg, 50 mg   and 100 mg Proof of concept established
Tamsulosin MR tablets 0.4mg Under development
Methylphenidate HCl ER Capsules 10 mg ,20 mg , 30 mg and 40 mg Under development
Dabigatran etexilate Capsules 75 mg, 110 mg, 150 mg Under development
Dexlansoprazole DR capsules 30 mg and 60 mg Under development
Trimetazidine MR Tablets 35 mg Under development
Hydralazine HCl + Isosorbide Dinitrate tablets 37.5mg/20mg Under development
Galantamine ER   Capsules 8mg/16mg/24mg Under development
Levodopa + Benserazide Dispersible Tablets 50mg + 12.5mg, 100mg +25mg Under development
Levodopa + Benserazide IR Capsules 50mg + 12.5mg, 100mg + 25mg, 200mg + 50mg Under development
Levodopa + Benserazide IR Tablets 50mg + 12.5mg, 100mg + 25mg, 200mg + 50mg Under development
Levodopa + Benserazide PR Capsules 100mg + 25mg, 200mg + 50mg Under development
Levodopa + Benserazide ER Tablets 200mg + 50mg To be initiated
Trimetazidine IR Tablets 20 mg To be initiated
Nafronyl MR Tabs 100 mg To be initiated
Aripiprazole ODT 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg To be initiated
Betahistine tablets 8mg, 16mg, 24mg To be initiated
Fluvoxamine Maleate Tablets 25 mg, 50 mg, 100 mg To be initiated
Fluvoxamine Maleate ER Capsules 100 mg, 150 mg To be initiated
Lamotrigine Dispersible /Chewable tabs 2mg, 5mg, 25mg,100mg To be initiated
Bempedoic Acid Tablets 180mg To be initiated
Lisdexamfetamine dimesylate Capsules 10mg, 20mg, 30mg, 40mg, 50mg, 60mg, 70mg To be initiated